Shunt Surgery for Hydrocephalus Complicating Cryptococcal Meningitis in Human Immunodeficiency Virus--Negative Patients

Po-chou Liliang; Cheng-Loong Liang; Wen-Neng Chang; Han-Jung Chen; Thung-Ming Su; Kang Lu; Cheng-Hsien Lu
September 2003
Clinical Infectious Diseases;9/1/2003, Vol. 37 Issue 5, p673
Academic Journal
From 1988 through 2001, 27 patients with cryptococcal meningitis who had hydrocephalus were identified and were treated by placement of ventriculoperitoneal (VP) shunts. To assess the predictive value of the response to VP shunts in terms of outcome in these patients, univariate analysis for variables was performed. Poor outcome was associated with a Glasgow Coma Scale score of ⩽8 (P<.001) and duration of altered consciousness of >48 h (P=.02). Use of VP shunts did not result in a good response or outcome in comatose patients. Thus, any delay in the diagnosis or treatment of patients with hydrocephalus could cause a deterioration of consciousness and is associated with poor outcome.


Related Articles

  • Cryptococcal meningitis in a human immunodeficiency virus negative patient with follicular lymphoma. Nandennavar, Manjunath; Karpurmath, Shashidhar; Santosh, K. V.; Rojaramani, P.; Ramakrishna, N. V. S. // Indian Journal of Medical & Paediatric Oncology;Jan-Mar2014, Vol. 35 Issue 1, p118 

    A letter to the editor is presented regarding the development of cryptococcal meningitis in a HIV negative patient with follicular lymphoma.

  • Advancing Translational Immunology in HIV-Associated Cryptococcal Meningitis. Williamson, Peter R. // Journal of Infectious Diseases;Jun2013, Vol. 207 Issue 12, p1793 

    The article discusses several studies on methods for treatment of human immunodeficiency virus (HIV) associated cryptococcal meningitis. It informs that Jarvis et al has conducted a study to examine cryptococcal-specific peripheral CD4 T-cell responses in HIV-infected patients with cryptococcal...

  • Ocular cryptococcosis as a presenting manifestation of cryptococcal meningitis in a patient with HIV. Chai, S.-M.; Teoh, S. C. // International Journal of STD & AIDS;May2012, Vol. 23 Issue 5, p377 

    We describe a case of cryptococcal meningitis in a patient known to have HIV who presented initially with ocular cryptococcosis. This case highlights to clinicians the need to be aware of this association and to carry out relevant investigations so as to treat these patients appropriately.

  • HIV/cryptococcal meningitis co-infection linked to immune reconstitution syndrome.  // Infectious Disease News;Nov2008, Vol. 21 Issue 11, p7 

    The article discusses the results of the study on the rate of cryptococcal immune reconstitution syndrome on patients co-infected with HIV and cryptococcal meningitis. The aim of the study was to determine the prevalence of systemic or local inflammatory reactions in treatment-naive patients...

  • Use of Ventriculoperitoneal Shunts to Treat Uncontrollable Intracranial Hypertension in Patients Who Have Cryptococcal Meningitis without Hydrocephalus. Liliang, Po-Chou; Liang, Cheng-Loong; Chang, Wen-Neng; Lu, Kang; Lu, Cheng-Hsien // Clinical Infectious Diseases;6/15/2002, Vol. 34 Issue 12, p64 

    Between 1997 and 2000, 4 human immunodeficiency virus-negative patients in our institution had cryptococcal meningitis with uncontrollable intracranial hypertension. All 4 patients were treated with antifungal drugs as well as ventriculoperitoneal (VP) shunts for intracranial hypertension....

  • Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa. Jarvis, Joseph N.; Lawn, Stephen D.; Vogt, Monica; Bangani, Nonzwakazi; Wood, Robin; Harrison, Thomas S. // Clinical Infectious Diseases;4/1/2009, Vol. 48 Issue 7, p856 

    Background. Cryptococcal meningitis is a leading cause of death in patients with acquired immunodeficiency syndrome and contributes substantially to the high early mortality in antiretroviral treatment (ART) programs in low-resource settings. Screening for cryptococcal antigen in patients who...

  • Combination Therapy for Human Immunodefficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where? Siedner, Mark J.; Campbell, Jeffrey I.; Kanters, Steve; Bennett, John E.; Thorlund, Kristian; Tsai, Alexander C.; Mills, Edward J. // Open Forum Infectious Diseases;Spring2015, Vol. 2 Issue 2, p1 

    A response is presented by Mark Siedner and colleagues to a letter to the editor on their article "Combination Therapy for Human Immunodefficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where?"

  • The Prognostic Factors Of Tuberculous Meningitis. Ahmadinejad, Zahra; Ziaee, Vahid; Aghsaeifar, Masood; Reiskarami, Seied Reza // Internet Journal of Infectious Diseases;2003, Vol. 3 Issue 1, p27 

    Background: Tuberculous meningitis (TBM) remains a serious health threat in developing countries. This study was aimed to analyze the prognostic factors and therapeutic outcomes of TBM. Patients and Method: Over a period of 10 years (1991- 2001), patients with the diagnosis of TBM were...

  • Prognostic factors of tuberculous meningitis: a single-center study. Jin Gu; Heping Xiao; Furong Wu; Yanping Ge; Jun Ma; Wenwen Sun // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 3, p4487 

    Objective: To investigate the prognostic factors of tuberculous meningitis (TBM) and develop strategies for the improvement of clinical efficacy. Methods: A total of 156 TBM patients were retrospectively reviewed. The demographic characteristics, underlying diseases, clinical features,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics